Table 1 Basic information of patient subjects from the transcriptomics study
From: Reversal gene expression assessment for drug repurposing, a case study of glioblastoma
| Â | Female | Male | Overall |
|---|---|---|---|
|  | (N = 135) | (N = 193) | (N = 328) |
GBM type | |||
Primary | 79 (58.5%) | 119 (61.7%) | 198 (60.4%) |
Recurrent | 56 (41.5%) | 74 (38.3%) | 130 (39.6%) |
Age | |||
Mean (SD) | 48.9 (12.7) | 48.3 (13.6) | 48.5 (13.2) |
Median [Min, Max] | 50.0 [19.0, 72.0] | 49.0 [11.0, 79.0] | 50.0 [11.0, 79.0] |
Overall Survival (Day) | |||
Mean (SD) | 605 (696) | 628 (649) | 618 (668) |
Median [Min, Max] | 366 [27.0, 4440] | 405 [19.0, 3820] | 387 [19.0, 4440] |
Missing | 4 (3.0%) | 6 (3.1%) | 10 (3.0%) |